ROCO

4197

Market cap8mUSD

Oct 08, Last price

8.80TWD

0.00%

0.80%

Jan 2017

-32.52%

IPO

-71.15%

Name

Visgeneer Inc

Chart & performance

D1W1MN

P/E

50.62

P/S

1.48

EPS

0.17

Div yield, %

—

Shrs. gr., 5y

0.45%

Rev. gr., 5y

0.35%

Revenues

179m

+54.68%

Net income

CFO

14m

Dividend

Jul 12, 20160.25 TWD/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Visgeneer, Inc. engages in the provision of biotechnology service. It specializes in blood glucose testers, blood glucose test tablets, blood ketone testers, blood ketone test tablets, and and skin care products. The company was founded on November 15, 2005 and is headquartered in Hsinchu, Taiwan.

Key people

Weijie Chen

Deputy General Manager · since 2013

Jiazhen Zhang

Head of Finance & Accounting · since 2022

Zongwu Cai

Director · since 2017

Kengshuo Dai

Chairman of the Board, General Manager

Bin He

Director · since 2005

Benxian Zhang

Director · since 2021

Ching-Lung Lee

Independent Director · since 2021

Jen-Chi Lu

Independent Director

Shang-Wu Yu

Independent Director · since 2021

URL

https://www.visgeneer.com/

IPO date

Oct 24, 2013

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title TWD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title TWD in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT